Sanofi India Reports Robust Q3'26 Profit Growth and Declares ₹75 Interim Dividend
Sanofi India Ltd · Press Release · 30 Oct 2026, 12:06 am
Sanofi India Reports Robust Q3'26 Profit Growth and Declares ₹75 Interim Dividend Sanofi India reported a 3.4% YoY rise in revenue from operations to ₹4,917 million for the quarter ended 30th Sep'26, while net profit surged 53.6% YoY to ₹1,167 million. Profit before tax and exceptional items rose 21.7% YoY to ₹1,577 million, supported by an 8% reduction in operating expenses and a 9% growth in the insulin portfolio (55% market share). The board declared an interim dividend of ₹75 per equity share (face value ₹10) with the record date set for 5th Nov'26.
Original exchange filing (PDF)
More announcements from Sanofi India Ltd
- Kindly refer the attachment · 18 Nov 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Sanofi India Limited has submitted to the Exchange, the unaudited financial results for the quarter and nine months ended 30th September 2026. · 29 Oct 2026
- Kindly refer the attachment · 29 Oct 2026
